These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31002127)

  • 21. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.
    Yun WK; Hu YM; Zhao CB; Yu DY; Tang JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2786-2793. PubMed ID: 31002129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
    Sun D; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SNHG1 enhances cell proliferation, migration, and invasion in cervical cancer.
    Liu Y; Yang Y; Li L; Liu Y; Geng P; Li G; Song H
    Biochem Cell Biol; 2018 Feb; 96(1):38-43. PubMed ID: 28930646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
    Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
    Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
    Wei LJ; Bai DM; Wang ZY; Liu BC
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
    Deng R; Zhang J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SNHG1 promotes sepsis-induced myocardial injury by inhibiting Bcl-2 expression via DNMT1.
    Zhang R; Niu Z; Liu J; Dang X; Feng H; Sun J; Pan L; Peng Z
    J Cell Mol Med; 2022 Jul; 26(13):3648-3658. PubMed ID: 35678255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p.
    Cui HX; Zhang MY; Liu K; Liu J; Zhang ZL; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6838-6844. PubMed ID: 30402848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p.
    Xu M; Chen X; Lin K; Zeng K; Liu X; Pan B; Xu X; Xu T; Hu X; Sun L; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2018 Sep; 17(1):141. PubMed ID: 30266084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA SNHG1 functions as a ceRNA to antagonize the effect of miR-145a-5p on the down-regulation of NUAK1 in nasopharyngeal carcinoma cell.
    Lan X; Liu X
    J Cell Mol Med; 2019 Apr; 23(4):2351-2361. PubMed ID: 29575772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non‑coding RNA SNHG1 promotes breast cancer progression by regulation of LMO4.
    Xiong X; Feng Y; Li L; Yao J; Zhou M; Zhao P; Huang F; Zeng L; Yuan L
    Oncol Rep; 2020 May; 43(5):1503-1515. PubMed ID: 32323846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
    Shi SL; Zhang ZH
    Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.
    Zhou H; Zhang Q; Huang W; He C; Zhou C; Zhou J; Ning Y
    Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
    Zhao QS; Ying JB; Jing JJ; Wang SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2.
    Guo Y; Bai M; Lin L; Huang J; An Y; Liang L; Liu Y; Huang W
    Biomed Pharmacother; 2019 Oct; 118():109272. PubMed ID: 31376657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UPF1 alleviates the progression of glioma via targeting lncRNA CYTOR.
    Zou SF; Yang XY; Li JB; Ding H; Bao YY; Xu J
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10005-10012. PubMed ID: 31799670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA PURPL promotes cell proliferation in liver cancer by regulating p53.
    Fu X; Wang Y; Wu G; Zhang W; Xu S; Wang W
    Mol Med Rep; 2019 Jun; 19(6):4998-5006. PubMed ID: 31059022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.